Proprietary Duck Cell Line Serves as Large-Scale Production-Suitable Cell Substrate Berlin, Germany, and Basel, Switzerland, June 26, 2018 / B3C newswire / -- ProBioGen AG, a premier German service & technology provider for complex therapeutic …
Wädenswil, Switzerland, June 26, 2018 / B3C newswire / -- Inthera Bioscience AG, a pre-clinical stage oncology company targeting the inhibition of protein-protein interactions with innovative small molecule chemistry, today announced that three senior …
Freiburg, Germany, June 21, 2018 / B3C newswire / -- CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters’ expansion as …
Lund, Sweden, June 20, 2018 / B3C newswire / -- TFS International is delighted to announce that Dr Suzanne Pavon has accepted the position of Executive Vice President, Quality Assurance. Dr Pavon is an entrepreneurial, quality focused, senior executive …
Technology Enables Clinicians to Non-Invasively Evaluate Brain Blood Flow Characteristics for Management of Patients with Neurological Disease Los Angeles, CA, USA, June 19, 2018 / B3C newswire / -- Neural Analytics, Inc., a medical robotics company …
San Ramon, CA, USA, June 15, 2018 / B3C newswire / -- International provider of SaaS-based track and trace and serialisation solutions, rfxcel, today announces its continued successful expansion in the UK and EMEA, with triple digit percentage revenue …
Burton-on-Trent, England, June 14, 2018 / B3C newswire / -- Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, has signed an exclusive agreement with Lukare Medical (‘Lukare’) to manage the supply and distribution …
Siemens becomes a preferred supplier for automation solutions Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future New automated product to debut at the ACHEMA 2018 trade show in Frankfurt …
Odense, Denmark, June 11, 2018 / B3C newswire / -- RSP Systems A/S, the non-invasive diagnostics company, announces that it has completed the first closing of a Series B funding round amounting to €6.5 million. The round remains open for a second closing …
CDMO launches the Vetter Open Innovation Challenge under the slogan ‘Injection 2.0’ Multi-disciplinary teams of participants will examine the applicability of digital trends to injection systems A User-Centered Innovation (UCI) approach will directly …
Boston, USA and London, UK, June 07, 2018 / B3C newswire / -- Orchard Therapeutics, a leading commercial stage biotech company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, today announced the …
In a Phase II clinic trial (SOV01), DCVAC/OvCa decreased the risk of progression or death in 1st line maintenance treatment of ovarian cancer by almost 60% The SOV02 Phase II clinical trial with DCVAC/OvCa showed prolonged survival in patients with ovarian …
Studies presented in collaboration with centers of excellence in cancer treatment and translational research CancerTYPE ID provided molecular resolution in the diagnosis of bone-predominant metastatic disease where traditional methods had been limited …
Expanding global oncology testing for clinical trials Wilmington, N.C., USA, June 01, 2018 / B3C newswire / -- Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO), and NeoGenomics Laboratories, Inc., a …
Company to Share Clinical Development Plans and Corporate Strategy with Potential Partners Cambridge, Mass., USA, May 31, 2018 / B3C newswire / -- Thrombolytic Science, LLC (TSI), a clinical stage vascular health company developing biotechnology products …
Candidate to expand Zai Lab’s early-stage R&D programs, with an anticipated IND Filing for clinical studies in psoriasis in 2019 Shanghai, China and Cambridge, UK, May 30, 2018 / B3C newswire / -- Zai Lab Limited (NASDAQ: ZLAB), a Shanghai-based …
Deqing, China, May 28, 2018 / B3C newswire / -- Shuwen Biotech Co. Ltd., an emerging leader in innovative diagnostic products and services announced today it has signed a partnership agreement with Bliss Biopharmaceutical Co., Ltd., a biopharmaceutical …
Merus Initiates a Phase 1 Clinical Trial of MCLA-158, a Bispecific Antibody Utilizing ADCC-enhancing GlymaxX® Technology Berlin, Germany, May 24, 2018 / B3C newswire / -- ProBioGen AG, a premier service & technology provider for complex therapeutic …
Cambridge, Mass., USA, May 24, 2018 / B3C newswire / -- Thrombolytic Science, LLC (TSI), a clinical stage vascular health company developing biotechnology products to treat thrombotic diseases such as heart attacks and stroke, today announced that it will …
Prague, Czech Republic, May 24, 2018 / B3C newswire / -- SOTIO, a biotechnology company owned by the PPF Group, announces today that the first patient was enrolled to the SP015 clinical trial of a combination of DCVAC/PCa, an active cellular immunotherapy, …
